CASTRATE-SENSITIVE

Clinical trials for CASTRATE-SENSITIVE explained in plain language.

Never miss a new study

Get alerted when new CASTRATE-SENSITIVE trials appear

Sign up with your email to follow new studies for CASTRATE-SENSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Veterans study aims to find best First-Line prostate cancer treatment

Disease control Recruiting now

This study is for veterans with prostate cancer that still responds to hormone therapy. It compares three different drugs (abiraterone, enzalutamide, and apalutamide) given alongside standard hormone therapy to see which one controls tumor growth best. About 192 veterans will par…

Matched conditions: CASTRATE-SENSITIVE

Phase: PHASE2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control

Last updated Jun 16, 2026 12:54 UTC

CASTRATE-SENSITIVE

Get alerted when new CASTRATE-SENSITIVE trials appear

Veterans study aims to find best First-Line prostate cancer treatment